CHILDS JOHN W 4/A

What Happened John W. Childs, a director of Veradermics, Inc. (MANE), purchased 294,117 shares of common stock on February 5, 2026 at $17.00 per share for a total of $4,999,989. The transaction is reported as a purchase (code P) and the Form 4 has been amended to correct the entity through which the shares were indirectly acquired.

Key Details

• Transaction date and price: 2026-02-05 — 294,117 shares at $17.00/share = $4,999,989 total.
• Transaction type: Purchase (P).
• Indirect ownership: The amendment clarifies the shares were indirectly acquired through the John W. Childs 2013 Revocable Trust (not J.W. Childs Associates (FL), L.P.).
• Reporting role: John W. Childs is Trustee of the John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power over these shares.
• Post-transaction holdings: The amendment specifies 294,117 shares are held by the revocable trust; the filing does not state total shares owned by the reporting person after the transaction.
• Filing status: This is an amended Form 4 filed on 2026-02-27 to correct the nature of indirect ownership; the original Form 4 was filed on 2026-02-05.

Context This was a direct purchase (a bullish signal in that insiders are buying), and the amendment only corrects which entity holds the shares (a revocable trust). No options, gifts, or sales are involved in this filing, and no indication of a 10b5-1 plan or tax-withholding was provided in the amendment.